XBI

SPDR S&P Biotech ETF

Up$80.09
+$1.44
(+1.83%)
As of 4:14:22 PM EDT | 10/21/19  |  Market Closed

XBI Trading Data

Open

$79.48

Low Price

$78.58

High Price

$80.35

Previous Last Price

$78.65

Bid Size

$80 X 900

Ask Size

$80.19 X 400

XBI Portfolio Data

AUM

$3,649,802,000

Shares

45,800

PE Ratio

17.55

Price / Book Ratio

4.35

Expense Ratio

0.35

Net Asset Value

$79.69

Volume

Volume

4,388,992

Avg. Volume (YDT)

4,756,969

Dollar Volume

$258,655,429

Weekly Avg. Volume

5,490,754

Monthly Avg. Volume

6,359,128

Quarterly Avg. Volume

4,780,730

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

Arrowhead Pharmaceuticals Inc. (ARWR)
2.02%
Seattle Genetics Inc. (SGEN)
2.01%
Medicines Company (MDCO)
1.93%
Ligand Pharmaceuticals Incorporated (LGND)
1.83%
Regeneron Pharmaceuticals Inc. (REGN)
1.77%
AbbVie Inc. (ABBV)
1.76%
Amgen Inc. (AMGN)
1.72%
Celgene Corporation (CELG)
1.71%
Mirati Therapeutics Inc. (MRTX)
1.68%
Sarepta Therapeutics Inc. (SRPT)
1.68%

Total XBI Holdings

Total Holdings: 121

Arrowhead Pharmaceuticals Inc. (ARWR)
2.02%
Seattle Genetics Inc. (SGEN)
2.01%
Medicines Company (MDCO)
1.93%
Ligand Pharmaceuticals Incorporated (LGND)
1.83%
Regeneron Pharmaceuticals Inc. (REGN)
1.77%
AbbVie Inc. (ABBV)
1.76%
Amgen Inc. (AMGN)
1.72%
Celgene Corporation (CELG)
1.71%
Mirati Therapeutics Inc. (MRTX)
1.68%
Sarepta Therapeutics Inc. (SRPT)
1.68%
Vertex Pharmaceuticals Incorporated (VRTX)
1.68%
Incyte Corporation (INCY)
1.67%
United Therapeutics Corporation (UTHR)
1.67%
Neurocrine Biosciences Inc. (NBIX)
1.66%
Repligen Corporation (RGEN)
1.64%
Gilead Sciences Inc. (GILD)
1.62%
Alnylam Pharmaceuticals Inc (ALNY)
1.61%
Biogen Inc. (BIIB)
1.57%
Blueprint Medicines Corp. (BPMC)
1.56%
Intercept Pharmaceuticals Inc. (ICPT)
1.54%
BioMarin Pharmaceutical Inc. (BMRN)
1.54%
Spark Therapeutics Inc. (ONCE)
1.54%
Alexion Pharmaceuticals Inc. (ALXN)
1.54%
Global Blood Therapeutics Inc (GBT)
1.51%
Exact Sciences Corporation (EXAS)
1.51%
SAGE Therapeutics Inc. (SAGE)
1.5%
Exelixis Inc. (EXEL)
1.46%
bluebird bio Inc. (BLUE)
1.44%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
1.43%
Ionis Pharmaceuticals Inc. (IONS)
1.41%
Invitae Corp. (NVTA)
1.39%
Amicus Therapeutics Inc. (FOLD)
1.35%
CareDx Inc. (CDNA)
1.35%
FibroGen Inc. (FGEN)
1.29%
Genomic Health Inc. (GHDX)
1.28%
ACADIA Pharmaceuticals Inc. (ACAD)
1.26%
Arena Pharmaceuticals Inc. (ARNA)
1.24%
Immunomedics Inc. (IMMU)
1.23%
Portola Pharmaceuticals Inc. (PTLA)
1.2%
Iovance Biotherapeutics Inc (IOVA)
1.2%
Ra Pharmaceuticals Inc. (RARX)
1.17%
REGENXBIO Inc. (RGNX)
1.17%
Ultragenyx Pharmaceutical Inc. (RARE)
1.11%
Myriad Genetics Inc. (MYGN)
1.11%
Insmed Incorporated (INSM)
1.02%
Agios Pharmaceuticals Inc. (AGIO)
1%
Alkermes Plc (ALKS)
0.98%
ArQule Inc. (ARQL)
0.96%
Esperion Therapeutics Inc. (ESPR)
0.95%
Natera Inc. (NTRA)
0.92%
PTC Therapeutics Inc. (PTCT)
0.84%
Madrigal Pharmaceuticals Inc. (MDGL)
0.77%
Veracyte Inc (VCYT)
0.76%
Coherus BioSciences Inc. (CHRS)
0.76%
Emergent BioSolutions Inc. (EBS)
0.76%
Xencor Inc. (XNCR)
0.72%
Alder Biopharmaceuticals Inc. (ALDR)
0.7%
Allakos Inc. (ALLK)
0.69%
Adverum Biotechnologies Inc (ADVM)
0.68%
Enanta Pharmaceuticals Inc. (ENTA)
0.64%
Halozyme Therapeutics Inc. (HALO)
0.63%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.62%
Editas Medicine Inc. (EDIT)
0.6%
Sangamo Therapeutics Inc. (SGMO)
0.6%
Fate Therapeutics Inc. (FATE)
0.59%
AnaptysBio Inc. (ANAB)
0.57%
Audentes Therapeutics Inc. (BOLD)
0.57%
Heron Therapeutics Inc (HRTX)
0.56%
Acceleron Pharma Inc (XLRN)
0.56%
Atara Biotherapeutics Inc (ATRA)
0.55%
Karyopharm Therapeutics Inc. (KPTI)
0.55%
Aimmune Therapeutics Inc (AIMT)
0.53%
Vanda Pharmaceuticals Inc. (VNDA)
0.49%
Viking Therapeutics Inc. (VKTX)
0.44%
Radius Health Inc (RDUS)
0.43%
Apellis Pharmaceuticals Inc. (APLS)
0.43%
Allogene Therapeutics Inc. (ALLO)
0.42%
Puma Biotechnology Inc. (PBYI)
0.4%
Vericel Corporation (VCEL)
0.4%
ZIOPHARM Oncology Inc. (ZIOP)
0.39%
Athenex Inc. (ATNX)
0.39%
Intrexon Corporation (XON)
0.39%
Eagle Pharmaceuticals Inc. (EGRX)
0.38%
Retrophin Inc. (RTRX)
0.38%
AMAG Pharmaceuticals Inc. (AMAG)
0.38%
Voyager Therapeutics Inc. (VYGR)
0.37%
Anika Therapeutics Inc. (ANIK)
0.36%
Epizyme Inc. (EPZM)
0.35%
Deciphera Pharmaceuticals Inc. (DCPH)
0.35%
OPKO Health Inc. (OPK)
0.34%
TG Therapeutics Inc. (TGTX)
0.33%
Intellia Therapeutics Inc. (NTLA)
0.3%
Dicerna Pharmaceuticals Inc. (DRNA)
0.3%
Flexion Therapeutics Inc. (FLXN)
0.29%
Twist Bioscience Corp. (TWST)
0.28%
G1 Therapeutics Inc. (GTHX)
0.28%
Achillion Pharmaceuticals Inc. (ACHN)
0.28%
Momenta Pharmaceuticals Inc. (MNTA)
0.27%
MacroGenics Inc. (MGNX)
0.27%
Stemline Therapeutics Inc. (STML)
0.27%
Spectrum Pharmaceuticals Inc. (SPPI)
0.26%
Krystal Biotech Inc. (KRYS)
0.26%
Turning Point Therapeutics Inc. (TPTX)
0.24%
Catalyst Pharmaceuticals Inc. (CPRX)
0.23%
Kura Oncology Inc. (KURA)
0.23%
Denali Therapeutics Inc. (DNLI)
0.22%
Cytokinetics Incorporated (CYTK)
0.21%
ImmunoGen Inc. (IMGN)
0.2%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.18%
Akcea Therapeutics Inc. (AKCA)
0.17%
BioCryst Pharmaceuticals Inc. (BCRX)
0.17%
Progenics Pharmaceuticals Inc. (PGNX)
0.16%
Rhythm Pharmaceuticals Inc. (RYTM)
0.15%
Akebia Therapeutics Inc. (AKBA)
0.15%
Rocket Pharmaceuticals Inc. (RCKT)
0.14%
Homology Medicines Inc. (FIXX)
0.12%
CytomX Therapeutics Inc. (CTMX)
0.12%
AVROBIO Inc (AVRO)
0.11%
Prothena Corp. Plc (PRTA)
0.08%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%

XBI Technicals

Alpha

-0.98

Beta

1.67

Leverage

Long

Standard Deviation

5.57

XBI Dividends

Dividend Date

2019-09-20

Latest Dividend

0.003

Annual Dividend

0.02

Annual Dividend Rate

0.02

Annual Dividend Yield

0.02

XBI Performance

YTD Return

11.62%

1 Year Return

-6.24%

3 Year Return

31.68%

5 Year Return

41.09%

10 Year Return

405.57%

XBI Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.